MTOR and pancreatic neoplasm: It is well known that the down-regulation of the mTOR pathway inhibits the translation of several RPs, while genome-wide analysis in pancreatic cancer cells have shown that RPs are among the top differentially translated genes upon treatment with mTOR inhibitor [14,15].